Rating History for Quince Therapeutics Inc. (QNCX) by Leerink

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/24/2026 Joseph P. Schwartz New Coverage Outperform
(N/A)
4.00
(N/A)
0.97
(18.88)
1846.39% Details